Related Experiment Video
Updated: Dec 24, 2025

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
Multimodality evaluation of transcatheter structural valve degeneration at long-term follow-up
Alfredo Nunes Ferreira-Neto1, Tania Rodriguez-Gabella1, Leonardo Guimaraes1
1Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Insights
Transcatheter heart valve (THV) performance gradually declines over 10 years, with structural valve degeneration (SVD) affecting 30% of patients. Leaflet issues, not valve geometry, were linked to THV SVD.
Area of Science:
- Cardiology
- Biomedical Engineering
- Medical Imaging
Background:
- Transcatheter heart valve (THV) replacement is a common procedure for aortic stenosis.
- Long-term hemodynamic performance and structural valve degeneration (SVD) of THVs require further investigation.
Purpose of the Study:
- To assess the long-term hemodynamic performance of THVs using serial transthoracic echocardiography (TTE).
- To determine the incidence, characteristics, and associated factors of THV structural valve degeneration (SVD) over a 10-year period.
Main Methods:
- A cohort of 212 patients who underwent transcatheter aortic valve replacement (TAVR) with >5 years follow-up were analyzed.
- Serial TTEs were performed up to 10 years post-procedure to evaluate valve hemodynamics and SVD.
- SVD was defined based on changes in transvalvular gradient, valve area, and aortic regurgitation severity.
Main Results:
- Transvalvular mean gradient increased and valve area decreased over time (P<.01).
- At 8 years, SVD occurred in 30.2% of patients (clinically relevant SVD in 9.3%).
- Transesophageal echocardiography showed thickened and reduced-mobility leaflets in most SVD cases; THV geometry did not impact SVD.
Conclusions:
- Gradual hemodynamic deterioration of THVs occurs over a decade, leading to SVD in approximately 30% of patients.
- Impaired leaflet morphology and mobility are common in SVD, but THV geometry is not a significant factor.
- Long-term echocardiographic monitoring is crucial for assessing THV durability and detecting SVD.
Introduction And Objectives:
We assessed the long-term hemodynamic performance of transcatheter heart valve (THV) by paired transthoracic echocardiography (TTE), and the incidence, characteristics and factors associated with THV structural valve degeneration (SVD).
Methods:
A total of 212 patients who underwent transcatheter aortic valve replacement and had a potential follow-up >5 years with at least 1 TTE ≥ 1-year postprocedure were included. All patients had a TTE at 1 to 5 years and 36 had another one at 6 to 10 years. SVD was defined as subclinical (increase >10mmHg in mean transvalvular gradient+decrease >0.3cm2 in valve area and/or new-onset mild or moderate aortic regurgitation) and clinically relevant (increase> 20mmHg in mean transvalvular gradient+decrease> 0.6cm2 in valve area and/or new-onset moderate-to-severe aortic regurgitation). Fifteen patients had a transesophageal echocardiography at the time of SVD diagnosis, and 85 an opportunistic computed tomography examination at 1 (0.5-2) years.
Results:
Transvalvular mean gradient increased and valve area decreased over time (P<.01). At 8 years of follow-up, SVD occurred in 30.2% of patients (clinically relevant: 9.3%). Transesophageal echocardiography revealed thickened and reduced-mobility leaflets in 80% and 73% of SVD cases, respectively. No baseline or procedural factors were associated with SVD. THV underexpansion (3.5%) or eccentricity (8.2%) had no impact on valve hemodynamics/SVD at follow-up.
Conclusions:
A gradual THV hemodynamic deterioration occurred throughout a 10-year period, leading to SVD in ∼30% of patients (clinically relevant in < 10%). Leaflet morphology/mobility were frequently impaired in SVD cases, but THV geometry did not influence valve hemodynamics or SVD.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation I: Introduction

